Fundamentals screen · refreshed after the Sep 28, 2026 close
Largest US companies: Healthcare
US-listed companies ranked by market capitalisation. Market capitalisation is shares outstanding multiplied by the latest close.
| # | Company | Price | Today | YTD | P/E | Mkt cap |
|---|---|---|---|---|---|---|
| 101 | CHEChemedHealthcare | $514.30 | +0.42% | +20.2% | 24.4× | $6.72B |
| 102 | HIMSHims & Hers HealthHealthcare | $28.78 | −2.18% | −11.4% | — | $6.71B |
| 103 | LQDALiquidiaHealthcare | $73.67 | +7.66% | +113.6% | 47.6× | $6.59B |
| 104 | LNTHLantheus HoldingsHealthcare | $99.74 | 0.00% | +49.9% | 23.7× | $6.51B |
| 105 | LGNDLigand PharmaceuticalsHealthcare | $314.10 | +4.17% | +66.1% | 31.8× | $6.26B |
| 106 | CGONCG OncologyHealthcare | $69.61 | +3.66% | +67.7% | — | $6.17B |
| 107 | BLCOBausch + LombHealthcare | $16.95 | +0.53% | −0.8% | — | $6.05B |
| 108 | SRRKScholar Rock HoldingHealthcare | $49.13 | +1.03% | +11.5% | — | $5.98B |
| 109 | KNSAKiniksa Pharmaceuticals InternationalHealthcare | $76.10 | +1.36% | +84.5% | 73.6× | $5.94B |
| 110 | GRALGRAILHealthcare | $132.63 | +4.52% | +55.0% | — | $5.92B |
| 111 | TVTXTravere TherapeuticsHealthcare | $61.57 | +3.58% | +61.1% | — | $5.80B |
| 112 | MMEDMiniMed GroupHealthcare | $20.49 | +2.55% | — | — | $5.76B |
| 113 | BLLNBillionToOneHealthcare | $121.72 | −1.10% | +48.7% | — | $5.74B |
| 114 | MIRMMirum PharmaceuticalsHealthcare | $87.96 | −1.94% | +11.4% | — | $5.71B |
| 115 | KODKodiak SciencesHealthcare | $89.92 | +177.96% | +221.6% | — | $5.65B |
| 116 | RDNTRadNetHealthcare | $71.81 | +1.44% | +0.6% | — | $5.65B |
| 117 | ORKAOruka TherapeuticsHealthcare | $84.19 | −0.32% | +177.8% | — | $5.57B |
| 118 | COGTCogent BiosciencesHealthcare | $31.86 | −1.39% | −10.3% | — | $5.53B |
| 119 | PTCTPTC TherapeuticsHealthcare | $65.95 | +5.23% | −13.2% | — | $5.50B |
| 120 | TFXTeleflex IncorporatedHealthcare | $127.38 | +4.35% | +4.4% | — | $5.40B |
| 121 | SHCSotera HealthHealthcare | $18.45 | +0.60% | +4.6% | 32.2× | $5.27B |
| 122 | CRSPCRISPR Therapeutics AGHealthcare | $54.09 | −0.26% | +3.1% | — | $5.23B |
| 123 | MMSIMerit Medical SystemsHealthcare | $87.00 | −0.57% | −1.3% | 35.7× | $5.19B |
| 124 | DFTXDefinium TherapeuticsHealthcare | $38.41 | +6.19% | — | — | $5.16B |
| 125 | IOVAIovance BiotherapeuticsHealthcare | $10.99 | −0.09% | +302.6% | — | $4.98B |
| 126 | ERASErascaHealthcare | $14.13 | −0.84% | +279.8% | — | $4.94B |
| 127 | DNTHDianthus TherapeuticsHealthcare | $87.83 | −0.81% | +113.1% | — | $4.91B |
| 128 | HAEHaemoneticsHealthcare | $105.79 | +0.47% | +32.0% | 50.0× | $4.81B |
| 129 | MANEVeradermics, IncorporatedHealthcare | $115.00 | −1.35% | — | — | $4.80B |
| 130 | ADPTAdaptive BiotechnologiesHealthcare | $28.51 | −3.13% | +75.6% | — | $4.55B |
| 131 | ABCLAbCellera BiologicsHealthcare | $13.92 | +9.61% | +307.0% | — | $4.51B |
| 132 | CONConcentra Group Holdings ParentHealthcare | $35.36 | +1.00% | +79.7% | 22.6× | $4.51B |
| 133 | LFSTLifeStance Health GroupHealthcare | $11.84 | 0.00% | +68.2% | 89.0× | $4.50B |
| 134 | INDVIndivior PharmaceuticalsHealthcare | $36.88 | +2.96% | +2.8% | 12.3× | $4.35B |
| 135 | HTFLHeartflowHealthcare | $49.92 | +1.53% | +71.3% | — | $4.34B |
| 136 | EWTXEdgewise TherapeuticsHealthcare | $39.79 | +1.14% | +60.3% | — | $4.32B |
| 137 | ITGRInteger HoldingsHealthcare | $126.38 | +0.03% | +61.1% | 33.5× | $4.30B |
| 138 | LIVNLivaNovaHealthcare | $77.21 | +0.76% | +25.5% | 22.6× | $4.25B |
| 139 | VKTXViking TherapeuticsHealthcare | $33.03 | −7.11% | −6.1% | — | $4.11B |
| 140 | ICUIICU MedicalHealthcare | $164.03 | −0.56% | +15.0% | 136.3× | $4.10B |
| 141 | TNGXTango TherapeuticsHealthcare | $24.30 | −2.49% | +174.3% | — | $4.10B |
| 142 | PBLSParabilis MedicinesHealthcare | $32.57 | +4.39% | — | — | $4.02B |
| 143 | CELCCelcuityHealthcare | $79.64 | +0.15% | −20.2% | — | $3.90B |
| 144 | RLAYRelay TherapeuticsHealthcare | $17.69 | +1.26% | +109.1% | — | $3.88B |
| 145 | NVSTEnvista Holdings Corporation Common stock, $0.01 par value per shareHealthcare | $23.73 | −0.92% | +9.3% | 40.1× | $3.81B |
| 146 | AMLXAmylyx PharmaceuticalsHealthcare | $29.85 | +1.22% | +147.1% | — | $3.81B |
| 147 | PLSEPulse Biosciences, Inc Common Stock (DE)Healthcare | $52.32 | +1.34% | +281.1% | — | $3.73B |
| 148 | IRTCiRhythm HoldingsHealthcare | $112.60 | +2.01% | −36.5% | — | $3.71B |
| 149 | IDYAIDEAYA BiosciencesHealthcare | $38.22 | +4.17% | +10.6% | — | $3.69B |
| 150 | VCYTVeracyteHealthcare | $45.23 | −0.44% | +7.4% | 31.8× | $3.64B |
Method & sources
Computed after each close from Massive / Polygon prices (split-adjusted), SEC filings, FINRA short-interest settlements and FMP earnings dates. Rows are rebuilt every session; a stock appears only when every criterion is met with current data. Full methodology
Informational screen, not a recommendation.